We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why You Should Retain Welltower Stock in Your Portfolio Now
Read MoreHide Full Article
Key Takeaways
Welltower's SHO portfolio set for SSNOI growth of 18.5-21.5% in 2025.
OM portfolio benefits from rising outpatient visits and strategic acquisitions.
$9.5B liquidity and lower net debt boost Welltower's financial flexibility.
Welltower Inc.’s (WELL - Free Report) senior housing operating (SHO) portfolio is well-poised to benefit from an aging population and a rise in healthcare expenditure by senior citizens. Moreover, favorable outpatient visit trends in the outpatient medical (OM) portfolio bode well for long-term growth. However, competition in the senior housing market poses a key concern.
What’s Aiding Welltower?
The senior citizen population is expected to rise in the coming years. This age cohort constitutes a major customer base of healthcare services and incurs higher healthcare expenditures than the average population, positioning Welltower’s SHO portfolio well to capitalize on this positive trend. In 2025, management anticipates the SHO same-store net operating income (SSNOI) to grow within 18.5-21.5%, driven by same-store revenue growth of 9.2%, occupancy rise of 360 basis points and expense increase of 5.25%.
Historically, there has been a favorable outpatient visit trend compared with inpatient admissions. Banking on this, the company is optimizing its OM portfolio and growing relationships with health system partners and deploying capital in strategic acquisitions. Given the favorable secular trends and growing need for value-based care, its efforts to strengthen its OM footprint will boost long-term growth.
WELL’s capital-recycling efforts highlight its prudent capital management practices and pave the way for long-term growth. From the beginning of the year through July 28, 2025, Welltower completed $3.96 billion of pro-rata gross investments, including $3.7 billion in acquisitions and loan funding, and $254.9 million in development funding. The company has also been disposing of assets simultaneously. From the beginning of the year through July 28, 2025, Welltower completed pro rata property dispositions of $408.9 million and loan repayments of $215.5 million.
Welltower has a healthy balance sheet position and ample liquidity to meet near-term obligations and fund its development pipeline. As of June 30, 2025, it had $9.5 billion of available liquidity, including $4.5 billion of cash & restricted cash and full capacity under its $5 billion line of credit. As of June 30, 2025, the net debt to adjusted EBITDA was 2.93X, improving from 3.68X year over year. Welltower’s debt maturities are well-laddered, with a weighted average maturity of 5.8 years, thereby enhancing its financial flexibility.
What’s Hurting Welltower?
Welltower faces competition from other healthcare companies such as Ventas (VTR - Free Report) and Healthpeak Properties (DOC - Free Report) regarding factors such as quality, price and the range of services provided. It also competes for reputation, location, and demographics of the population in the surrounding area and the financial condition of its tenants and operators. Such competition from companies like VTR and DOC is likely to limit the company’s power to significantly raise its top line and ink deals at attractive rates.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Here's Why You Should Retain Welltower Stock in Your Portfolio Now
Key Takeaways
Welltower Inc.’s (WELL - Free Report) senior housing operating (SHO) portfolio is well-poised to benefit from an aging population and a rise in healthcare expenditure by senior citizens. Moreover, favorable outpatient visit trends in the outpatient medical (OM) portfolio bode well for long-term growth. However, competition in the senior housing market poses a key concern.
What’s Aiding Welltower?
The senior citizen population is expected to rise in the coming years. This age cohort constitutes a major customer base of healthcare services and incurs higher healthcare expenditures than the average population, positioning Welltower’s SHO portfolio well to capitalize on this positive trend. In 2025, management anticipates the SHO same-store net operating income (SSNOI) to grow within 18.5-21.5%, driven by same-store revenue growth of 9.2%, occupancy rise of 360 basis points and expense increase of 5.25%.
Historically, there has been a favorable outpatient visit trend compared with inpatient admissions. Banking on this, the company is optimizing its OM portfolio and growing relationships with health system partners and deploying capital in strategic acquisitions. Given the favorable secular trends and growing need for value-based care, its efforts to strengthen its OM footprint will boost long-term growth.
WELL’s capital-recycling efforts highlight its prudent capital management practices and pave the way for long-term growth. From the beginning of the year through July 28, 2025, Welltower completed $3.96 billion of pro-rata gross investments, including $3.7 billion in acquisitions and loan funding, and $254.9 million in development funding. The company has also been disposing of assets simultaneously. From the beginning of the year through July 28, 2025, Welltower completed pro rata property dispositions of $408.9 million and loan repayments of $215.5 million.
Welltower has a healthy balance sheet position and ample liquidity to meet near-term obligations and fund its development pipeline. As of June 30, 2025, it had $9.5 billion of available liquidity, including $4.5 billion of cash & restricted cash and full capacity under its $5 billion line of credit. As of June 30, 2025, the net debt to adjusted EBITDA was 2.93X, improving from 3.68X year over year. Welltower’s debt maturities are well-laddered, with a weighted average maturity of 5.8 years, thereby enhancing its financial flexibility.
What’s Hurting Welltower?
Welltower faces competition from other healthcare companies such as Ventas (VTR - Free Report) and Healthpeak Properties (DOC - Free Report) regarding factors such as quality, price and the range of services provided. It also competes for reputation, location, and demographics of the population in the surrounding area and the financial condition of its tenants and operators. Such competition from companies like VTR and DOC is likely to limit the company’s power to significantly raise its top line and ink deals at attractive rates.